Publication | Open Access

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

Breast OncologyOncologyClinical TrialsGynecologyBreast CancerMenopausePharmacotherapyPremenopausal StatusMedicineBreast Cancer DiagnosisWomen's HealthAdjuvant LetrozoleMenopause Hormone Therapy